VANCOUVER, B.C. – October 15, 2014 – CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the third quarter ended September 30, 2014, after market close on Monday, October 27, 2014.
A telephone conference call hosted by management to discuss the financial results will be held on Tuesday, October 28, 2014 at 10 am ET.
The telephone numbers for the conference call are (888) 231-8191 or (647) 427-7450
At the call’s completion, an audio replay will be available by calling (855) 859-2056 or (416) 849-0833 and using passcode 13807405. The phone replay will be available until November 11, 2014.
About CRH Medical Corporation:
CRH Medical Corporation is a North American company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases. The Company’s product, the CRH O’Regan System, is a single use, disposable, hemorrhoid treatment that is safe and highly effective in treating hemorrhoid grades I – IV. The O’Regan System is rapidly emerging as the standard of care with gastroenterologists who treat hemorrhoids. In addition to the product, CRH Medical delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its web-based platform to connect doctors with patients as well as educating its increasing customer base of physicians.
For more information, please contact:
Edward Wright, Chief Executive Officer
CRH Medical Corporation
604.633.1440 x1008
ewright@crhmedcorp.com
or
Adam Peeler, Media and Investor Relations
TMX Equicom
416.815.0700 x 225
apeeler@tmxequicom.com